The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...

The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

The global recommendation – issued Monday at the International AIDS Conference in Kigali, Rwanda – comes about a month after ...

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

This isn't about managing the AIDS pandemic. It's about ending it -- and letting a new generation grow and thrive free of its threat.

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

As science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal ...